𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Single-dose pharmacokinetics of leuprolide in humans following intravenous and subcutaneous administration

✍ Scribed by Lawrence T. Sennello; Richard A. Finley; Sou-Yie Chu; Cheryl Jagst; Devorah Max; Douglas E. Rollins; Keith G. Tolman


Publisher
John Wiley and Sons
Year
1986
Tongue
English
Weight
359 KB
Volume
75
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Human dolasetron pharmacokinetics: I. Di
✍ Harold Boxenbaum; Todd Gillespie; Kathleen Heck; William Hahne πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 471 KB πŸ‘ 2 views

Dolasetron is a 5-hydroxytryptamine antagonist active at type 111 receptors; it is presently undergoing clinical evaluation for the reduction/prevention of cancer chemotherapyinduced nausea and vomiting. Following intravenous administration to healthy male subjects of doses ranging from 0.6 to 5 mg

Pharmacokinetics of progesterone in ovar
✍ Nutan K. Gangrade; F. Douglas Boudinot; Dr James C. Price πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 367 KB πŸ‘ 2 views

The pharmacokinetics of progesterone were characterized in ovariectomized female rats. Progesterone was administered intravenously at a dose of 500 pg kg-'. Serum progesterone concentrations were determined by radioimmunoassay. Serum concentrations of progesterone were best described by a two-compar

Pharmacokinetics of glucuronidation of p
✍ K. K. Midha; R. M. H. Roscoe; T. W. Wilson; J. K. Cooper; J. C. K. Loo; A. Ho-Ng πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 336 KB πŸ‘ 2 views

## Abstract Pharmacokinetic and bioavailability parameters of propranolol were estimated in 10 healthy adult subjects after single oral doses of two commercial tablet formulations of propranolol hydrochloride (2 Γ— 40 mg). Plasma concentrations of propranolol were determined by a high‐performance li

Human dolasetron pharmacokinetics: II Ab
✍ Harold Boxenbaum; Todd Gillespie; Kathleen Heck; William Hahne πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 485 KB πŸ‘ 2 views

## Abstract Dolasetron is a 5‐hydroxytryptamine antagonist active at type III receptors; it is presently undergoing clinical evaluation for the reduction/prevention of cancer chemotherapyinduced nausea and vomiting. A previous study demonstrated that following intravenous administration to healthy